The utility of whole-body diffusion-weighted MRI for delineating regions of interest in PET
暂无分享,去创建一个
Martin O. Leach | David J. Collins | Matthew D. Blackledge | Dow-Mu Koh | D. Collins | D. Koh | M. Leach | M. Blackledge | S. Chua | S. Chua
[1] M. Morris,et al. Imaging therapeutic response in human bone marrow using rapid whole‐body MRI , 2004, Magnetic resonance in medicine.
[2] G Lucignani,et al. The use of standardized uptake values for assessing FDG uptake with PET in oncology: a clinical perspective , 2004, Nuclear medicine communications.
[3] John C Waterton,et al. Qualification of imaging biomarkers for oncology drug development. , 2012, European journal of cancer.
[4] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[5] B A Turlach,et al. Assessment of tumour response with 18F-fluorodeoxyglucose positron emission tomography using three-dimensional measures compared to SUVmax—a phantom study , 2008, Physics in medicine and biology.
[6] V. Wedeen,et al. Reduction of eddy‐current‐induced distortion in diffusion MRI using a twice‐refocused spin echo , 2003, Magnetic resonance in medicine.
[7] D. Collins,et al. Computed diffusion-weighted MR imaging may improve tumor detection. , 2011, Radiology.
[8] T. Takahara,et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. , 2004, Radiation medicine.
[9] R. Boellaard,et al. Effects of noise, image resolution, and ROI definition on the accuracy of standard uptake values: a simulation study. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.